RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Iowa City, IA · +40 more sites
3 recruiting multiple sclerosis studies with a site in Iowa City, IA.
Sponsor: TG Therapeutics, Inc.
Iowa City, IA · +40 more sites
Sponsor: National Tuberous Sclerosis Association
Iowa City, IA · +23 more sites
Sponsor: University of Iowa
Iowa City, IA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.